今年的医药类股比全球市场的表现还差。
Pharmaceutical shares have underperformed the global market this year.
在这种背景下，我国医药企业不可能长久地把自己局限在国内市场上，必须走出国门，参与全球竞争。
Instead it is necessary for them to go abroad to take part in the compititions of world market.
另一家医药保健信息咨询公司，艾美仕(IMS Health)计算出2009年七大新兴的药品市场将构成全球总销售增长的半数。
IMS Health, another consultancy, calculates that the seven biggest emerging pharma markets made up more than half of the global industry's total sales growth in 2009.
应用推荐